Stabilized pharmaceutical peptide compositions

Details for Australian Patent Application No. 2004243531 (hide)

Owner Novo Nordisk A/S

Inventors Engelund, Dorte Kot; Juul-Mortensen, Claus

Agent Shelston IP

Pub. Number AU-B-2004243531

PCT Pub. Number WO2004/105781

Priority PA 2003 00819 03.06.03 DK; 60/476,279 05.06.03 US; PA 2004 00075 19.01.04 DK; 60/538,525 22.01.04 US

Filing date 3 June 2004

Wipo publication date 9 December 2004

Acceptance publication date 5 November 2009

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105781 Priority application(s): WO2004/105781

5 November 2009 Application Accepted

  Published as AU-B-2004243531

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243536-Satiety enhancing food products

2004243524-Medicament for internal application, in particular against cancerous diseases